{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-100350","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2026-09-16T12:00:14+00:00","discovered_at":"2026-09-16T12:05:00.282780+00:00","generated_at":"2026-09-16T12:05:32.367099+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Allarity wins Japanese patent for stenoparib DRP companion diagnostic; Japan protection runs to 2039","bullets":["Japan Patent Office granted Japanese Patent No. 7917283 covering stenoparib-specific DRP companion diagnostic; Japan protection extends into 2039.","Patent covers DRP methods predicting clinical benefit from stenoparib via tumor gene-expression profiles and patient-selection methods.","Prior stenoparib DRP protection secured in US through April 2042, plus selected European jurisdictions and Australia; other filings pending.","CEO Thomas Jensen cites Japan as key pharma market and home of Eisai, original stenoparib developer, supporting drug's developability."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-100350","json":"https://secwatch.observer/filing/0001213900-26-100350.json","markdown":"https://secwatch.observer/filing/0001213900-26-100350.md","text":"https://secwatch.observer/filing/0001213900-26-100350.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026100350/0001213900-26-100350-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026100350/ea0305570-8k_allarity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T12:05:32.367099+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}